P2B001/003 New York — New York, New York

P2B001/003 New York is a clinical research site located in New York, New York, United States 10029.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

P2B001/003 New York has participated in 1 clinical trials.

Therapeutic areas: Parkinson Disease, Early Parkinson's Disease.

Sponsors: Pharma Two B Ltd..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for P2B001/003 New York?

P2B001/003 New York has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has P2B001/003 New York conducted?

P2B001/003 New York has 1 clinical trials on record. Their work covers Parkinson Disease, Early Parkinson's Disease.

Is P2B001/003 New York accredited by Crixeo Health?

P2B001/003 New York has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about P2B001/003 New York?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.